Your browser doesn't support javascript.
loading
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.
Raimondi, Alessandra; Di Maio, Massimo; Morano, Federica; Corallo, Salvatore; Lonardi, Sara; Antoniotti, Carlotta; Rimassa, Lorenza; Sartore-Bianchi, Andrea; Tampellini, Marco; Ritorto, Giuliana; Murialdo, Roberto; Clavarezza, Matteo; Zaniboni, Alberto; Adamo, Vincenzo; Tomasello, Gianluca; Petrelli, Fausto; Antonuzzo, Lorenzo; Giordano, Monica; Cinieri, Saverio; Longarini, Raffaella; Bergamo, Francesca; Niger, Monica; Antista, Maria; Peverelli, Giorgia; de Braud, Filippo; Di Bartolomeo, Maria; Pietrantonio, Filippo.
Afiliación
  • Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Di Maio M; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Torino, Italy.
  • Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Corallo S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Lonardi S; Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto - IRCCS, Padua, Italy.
  • Antoniotti C; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
  • Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy.
  • Tampellini M; Department of Oncology, AOU San Luigi di Orbassano, University of Torino, Orbassano, Italy.
  • Ritorto G; Colorectal Cancer Unit, Medical Oncology Division 1, Azienda Ospedaliero-Universitaria Città Della Salute e Della Scienza, Torino, Italy.
  • Murialdo R; Department of Internal Medicine, University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy.
  • Clavarezza M; Medical Oncology Unit, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
  • Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Adamo V; Medical Oncology Unit A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy.
  • Tomasello G; Medical Oncology Unit, ASST Ospedale di Cremona, Cremona, Italy.
  • Petrelli F; Medical Oncology Unit, Oncology Department, ASST Bergamo Ovest, Treviglio, Italy.
  • Antonuzzo L; Department of Medical Oncology, Oncology Unit, AOU Careggi, Florence, Italy.
  • Giordano M; Medical Oncology Unit, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy.
  • Cinieri S; Medical Oncology Unit, Ospedale Antonio Perrino, Brindisi, Italy.
  • Longarini R; Medical Oncology Unit, Azienda Ospedaliera San Gerardo, Monza, Italy.
  • Bergamo F; Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto - IRCCS, Padua, Italy.
  • Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Antista M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Peverelli G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy.
  • Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
Eur J Cancer ; 135: 230-239, 2020 08.
Article en En | MEDLINE | ID: mdl-32623288
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Biomarcadores de Tumor / Genes ras / Antineoplásicos Inmunológicos / Panitumumab / Mutación Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Biomarcadores de Tumor / Genes ras / Antineoplásicos Inmunológicos / Panitumumab / Mutación Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Italia